Purified type A botulinum toxin of about 106 mouse 50% lethal doses per ml was >99.9% inactivated when incubated at pH 7.4 for 30 min at 37°C in 20 mM 1,10-phenanthroline (PTL) or 2,2'-dipyridyl (DPD) and was 96% inactivated when incubated in 70 mM 8-hydroxyquinoline-5-sulfonic acid (HQL), but was not affected when incubated in 200 mM EDTA. When used as a representative of the chelating agents, PTL inactivated >99.9% of toxicity in the culture filtrate of C. botulinum type A, B, and E strains. Highly purified tetanus toxin at 2.5 x 105 50% lethal doses per ml lost all toxicity in 40 mM PTL or 150 mM DPD but was not detectably affected by 100 mM HQL (the highest concentration possible). Toxin inactivation by 20 mM PTL was completely blocked when the PTL was prereacted with an equimolar amount of Zn2+ and significantly reduced when it was preincubated with one-third its molar amount of Fe2+. DPD at 20 mM had little toxin-inactivating potency when preincubated with an equimolar amount of Zn2+ and only some of this potency when preincubated with an equimolar amount of Fe2+. Toxicity was not recovered by adding Zn2+ or Fe21 to PTL-treated toxin. Neutron activation analysis of type A toxin showed that for each toxin molecule present, there was 1 atom of Fe, 0.4 atom of Zn, and 22 to 55 atoms each of Ca and Mg. The biological activity of botulinum toxin seems to depend on a metal component, which is likely to be Fe.
The antigenicaily different Clostridium botulinum neurotoxin types in their fully toxic states are similar molecules. They are dichain proteins of Mr ca. 150,000, composed of an H subunit of Mr ca. 100,000 and an L subunit of Mr ca. 50,000. Since their electrophoretic separation has required pretreatment of the dichains with a disulfide-reducing agent, such as 2-mercaptoethanol or dithiothreitol, the subunits are considered to be covalently joined by disulfide linkage (14, 15) .
Type A botulinum toxin purified by a modification of a published method resolved, as expected, into its subunits when subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis after being treated with 2-mercaptoethanol. However, when electrophoresed after different holding periods at 4°C without being treated with 2-mercaptoethanol or dithiothreitol, the toxin showed progressively smaller amounts of dichains and correspondingly larger amounts of subunits (1) without a change in specific toxicity of about 3 x 108 mouse 50% lethal doses (LD50) per mg of protein.
Dithiothreitol and 2-mercaptoethanol are used in sodium dodecyl sulfate-polyacrylamide gel electrophoresis because of their ability to reduce disulfide bonds, but they also bind metals (5) . Since dithiothreitol inactivates botulinum toxin (16) , the possibility that better-known chelating agents have the same effect was examined. Practically all the toxicity in a purified type A botulinum toxin sample was inactivated in a preliminary study in which 1,10-phenanthroline (PTL) was used as a representative.
The present communication, describing a fuller study of the preliminary finding, reports that botulinum and tetanus toxins are inactivated by chelating agents lacking the property of cleaving disulfide bonds.
MATERIALS AND METHODS
Toxins. The botulinum toxin used in most experiments was the purified preparation obtained from C. botulinum type A strain 62A (1) . Other botulinum toxin samples were * Corresponding author.
cell-free filtrates made of 4-to 5-day-incubated broth cultures of type A strain Hall, type B strain Okra, and type E strain Alaska E43. Type E toxin was activated immediately before use with trypsin whose chymotryptic contaminant was inactivated (Sigma Chemical Co., St. Louis, Mo.). Tryptic activity was stopped with soybean trypsin inhibitor (7) .
Tetanus toxin was a commercial preparation (CalbiochemBehring, La Jolla, Calif.) reported to be electrophoretically homogeneous and having 360 flocculating units per mg of protein. In agreement with the value for pure tetanus toxin (1.5 x 107 mouse LD5Jmg of protein) (13), the sample had 2.2 x 107 LD5Jmg of protein when intraperitoneally titrated in this laboratory. Since its specific toxicity was about 1/10 that of the purified botulinum toxin used in the present study, tetanus toxin was tested at about 1/10 the toxic level of the botulinum toxin so that the amounts of the two proteins would be about equal.
Chelating agents. PTL, 2,2'-dipyridyl (DPD), 8- The effect of pH on the toxin-inactivating potency of PTL was studied by a similar procedure, in which the chelator was added to the toxin samples before the incubations. These tests included a chelator-free control for each toxin sample.
Chelator The test and control mixtures were dialyzed (see below) before being assayed for their toxicity.
The indicated volumes and concentrations result in a chelator-to-metal molar ratio of 1:1. Other molar ratios were prepared by using the appropriate concentration of the metal salt solution.
Toxicity assay. Botulinum toxins were routinely assayed by injecting 0.1 ml of sample into the tail veins of three or four albino mice weighing 18 to 23 g. The average minutes to death after challenge was converted to intraperitoneal LD50 from a standard curve which showed in a log-log plot the time to death (in minutes) of mice given intravenous injections (of known intraperitoneal LD50) of the toxin type being titrated (2) .
The low toxicities in many of the chelator-treated botulinum toxin samples gave death times outside the linear part of the standard curve. These samples and tetanus toxin were titrated by the intraperitoneal quantal method (16) , in which the highest dilution that kills mice within 3 days is taken as the measure of toxicity. Serial doubling dilutions were used when precise values were needed; serial 10-fold dilutions were used when less precise titrations sufficed. The dilutions were made with pH 6.2 buffer, and 0.5-ml samples of the dilutions were tested intraperitoneally in at least two mice.
Tetanus toxin treated with the higher chelator concentrations and botulinum toxin treated with EDTA could not be directly assayed because of the toxic effect of the chelators. These samples were dialyzed for 30 to 60 min at room temperature against 2 liters of buffer. The dialysis reduced the concentration of the chelator to a nonlethal level without detectably affecting the toxicity level of tetanus or botulinum toxin.
Metal ion-chelator mixtures were highly toxic for mice, so that toxin incubated in such a mixture could not be titrated because of the non-botulinum toxin factor(s). The interfering agents were removed by dialysis for 15 to 18 h, during which the dialyzing buffer (2 liters) was changed three times. Analysis of toxin for metals. Instrumental neutron activation analysis was used to determine the content of metals in botulinum toxin. Two preparations purified at different times from the same production lot of type A toxin were examined. The samples were concentrated with Aquacide (molecular weight, 20,000; Calbiochem-Behring) until the protein concentration was higher than 3.6 mg/10 ml. They were then exhaustively dialyzed against 0.15 M HEPES buffer (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [pH 7.0]; Sigma) in reagent grade water. The concentrated and dialyzed samples (10 ml of each) were pipetted into separate 15-ml polyethylene flip-top tubes that are suitable for instrumental neutron activation analysis. A blank of 10 ml of HEPES buffer was prepared for each toxin sample.
The four solutions were dried at 35°C in a vacuum oven until their weights did not change in three weighings done at 24 h intervals. The amount of dried material in a tube was obtained by subtracting the tare weight of that tube. The amount of dried toxin was then obtained by subtracting the weight of dried buffer in its blank.
The dried samples were dissolved in 6.0 ml of 0. (3, 4, 6) . RESULTS Inactivation of toxins. Purified type A botulinum toxin lost almost all toxicity when incubated at pH 7.4 for 30 min at 37°C in the presence of 20 mM PTL or DPD or 70 mM HQL; it was not affected by 200 mM EDTA (Table 1) . When PTL was used as a representative of the chelators, 40 mM inactivated essentially all the toxicities in crude preparations of botulinum toxin types A, B, and E (Table 2) . Deferoxamine did not inactivate purified type A toxin.
Consideration was given to the possibility that the chelators made mice resistant to toxin and thereby gave the impression of having inactivated the toxin. Mice were given an intravenous injection of 0.1 ml of 20 mM PTL or DPD, 70 mM HQL, or physiological saline and then challenged 15 min later with an intravenous injection of 0.1 ml of purified botulinum toxin. Since the times to death of mice receiving a chelator were the same as those of mice pretreated with (Table 3) .
Chelator concentrations. The inactivating effects of several chelator concentrations were plotted (Fig. 1) as percent residual toxicity versus the log concentration of chelator (micromolar) (instead of the conventional -log M). The dose-response curves of the different chelators were basically similar in shape.
Chelator-metal ion mixtures. PTL retained full toxin-inactivating potential when mixed with Zn2+ in a 3:1 (chelatorto-metal ion) molar ratio but lost almost all activity in the 1:1 mixture (Table 4) . PTL-Fe2+ combinations were different; the chelator lost some toxin-inactivating property in the 3:1 mixture but had more, instead of less, effect on toxicity in the 1:1 and 1:2 mixtures. Both Zn2+ and Fe2' blocked the toxin-inactivating effect of DPD (Table 4 ). The effect of Fe2+ on the chelator was quantitative, in that DPD in the 1:1 mixture had less toxininactivating effect than in the 3:1 mixture.
Effects of pH. Botulinum toxin samples in the pH 5.5 to 7.0 range did not lose toxicity when incubated at 37°C and then at room temperature (Fig. 2) . Toxicity loss occurred above or below this pH range, with greater loss occurring at pH levels which were further from the range in which there is no toxicity loss.
The experiment was repeated, with the difference that 10 mM PTL was present in the test mixtures and absent from the corresponding controls. The chelator did not inactivate toxin at pH 5.5 through 7.0 (Fig. 3) . It had only a slight effect at pH 7.2 (not shown), but the toxicity of pH 7.4 samples was much lower than that expected from the pH acting by itself (Fig. 2) . Samples of pH 9.0 had only about 35% of their original toxicity, but this level was further reduced by about 95% when PTL was present.
Reactivating toxicity. Tests were done to find whether pH-inactivated toxin could be reactivated by adjusting the (Fig. 4) (Table 6 ).
DISCUSSION
The inactivation by chelating agents of botulinum toxin in the purified state and in culture fluids is presumptive evidence that a metal is needed for the toxin to express its biological activity. Inactivation of tetanus toxin by some of the same chelators suggests that this toxin, whose primary molecular properties are comparable to those of botulinum toxin (13, 14) , also has an essential metal. These observations, however, do not prove the essential-metal hypothesis, since a chelator could be inactivating the toxin by a mechanism unrelated to its metal-binding property.
A chelator that inactivates toxin by binding with a metal should lose some of this effect if its metal-binding sites are saturated before being added to the toxin solution (17) . The chelator can be blocked by metals other than the essential metal of the protein, provided that its affinity for the chelator is at least as high as that of the essential metal.
The expected loss in toxin-inactivating potency was obtained when PTL was preincubated with Zn2+ and DPD was prereacted with Zn2+ or Fe2+ in 1:1 (chelator to metal, mole/mole) mixtures. PTL pretreated with Fe2+ in a 3:1 mixture had less effect on toxin than the untreated chelator did, but in 1:1 and 1:2 mixtures it apparently had more, instead of less, toxin-inactivating effect than in the 3:1 mixture. The surprising quantitative effects of PTL-Fe2+ mixtures cannot be explained, but may be related in some way to the unusually high stability of the 3:1 complex (17) .
Hydrogen ions have strong affinity for metal-binding sites in proteins, so that a metalloprotein loses its metal as it becomes protonated under low-pH conditions. Hydroxyl ions are highly reactive with metals, so that under high-pH 4 . Effect of pH on the toxicity of type A botulinum toxin. Symbols: *, inactivation at indicated pH; X, toxicity after adjusting the sample to pH 6.4. conditions they compete for metals in proteins. These different competitions make a metalloprotein unstable at both pH extremes (18) . The pH-related inactivations of botulinum toxin can therefore be another indication that the biological activity of botulinum toxin depends on a metal component. The effects of pH on the toxicity of type A, E, and F toxins have been previously reported (11, 12) . The dose-response curves showing the degrees of toxin inactivation given by different concentrations of a chelator are similar in shape to those of curves for chelators inactivating metalloenzymes (9, 10) .
Neutron activation analysis found 1 atom of Fe, about 0.5 atom of Zn, and more than 20 atoms of Ca and Mg for each type A toxin molecule in the samples. Since the highest concentration of the essential metal of a protein would be expected to be a few atoms per protein molecule, Ca and Mg were unlikely to be the metals needed for toxicity. This conclusion is supported by the observation that EDTA, a chelator with high affinity for these two metals (8), had little effect on toxin.
Zn was unlikely to be the essential metal, since its concentration is lower than the expected minimum of 1 atom per protein molecule. Fe was the only candidate left by the elimination process. The experimentally determined 1.09 atom of Fe per toxin molecule, when rounded to 1.0 atom, gives a stoichiometry appropriate for an essential metal.
Since the toxin is inactivated by PTL, which binds Fe2' but not Fe3", but not by deferoxamine, which efficiently binds Fe3+ but not Fe2 , the essential metal in botulinum toxin appears to be the ferrous form.
Most of the toxicity that disappeared when the toxin solution was made to pH 9.2 was recovered when the Since a metal having such a function is held in place by coordination bonds formed with several ligands in the protein, removal of the metal could change the spatial relationship of these ligands. In such a situation, returning the metal to its original position could be difficult, so that the effect of the chelator on the toxin is likely to be irreversible.
